Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-22 · accession 0001285550-23-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-23 | 2023-02-22 | CLPT | STIGALL L. JEREMY | GM, Biologics, Drug Delivery | F - Tax | $8.55 | -514 | 42.9K | -1% | -$4,395 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | F | D | 514 | $8.55 | 42,906 | D | — | — | (F1) Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. |